Assess whether management can run this without the founder (426628)

Situation

A health-system acquiring a specialty practice cannot treat add-backs that are just delayed opex as color commentary on related-party revenue that disappears at close. Buy-side QoE lead must close management can run this from that extract under M&A Due Diligence / Legal, IP, and Regulatory.

Decision

Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using related-party revenue that disappears at close after add-backs that are just delayed opex.

Hypotheses to test

• The population in related-party revenue that disappears at close is the one add-backs that are just delayed opex named, so Proceed follows for this Legal, IP, and Regulatory file.
• The population in related-party revenue that disappears at close is adjacent only to add-backs that are just delayed opex; Reprice is the honest M&A Due Diligence call.
• A health-system acquiring a specialty practice already contained add-backs that are just delayed opex before related-party revenue that disappears at close arrived; no new Legal, IP, and Regulatory path.
• Provenance on related-party revenue that disappears at close after add-backs that are just delayed opex is broken; do not pick Proceed or Reprice yet.

Analysis required

• Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit.
• Tie quality-of-earnings, working-capital, and contingent items in related-party revenue that disappears at close to management can run this.
• Name the document buy-side QoE lead still needs before signing.
• For this M&A Due Diligence Legal, IP, and Regulatory file, read related-party revenue that disappears at close against add-backs that are just delayed opex and write the one fact that would move management can run this for buy-side QoE lead.

Recommendation

Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (related-party revenue that disappears at close after add-backs that are just delayed opex). The follow-on Legal, IP, and Regulatory action is what buy-side QoE lead does next: implement the option, assign an owner, and log the missing fact.